Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""HIV-1"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 81009
Tytuł:
Next-Generation Sequencing Reveals a High Frequency of HIV-1 Minority Variants and an Expanded Drug Resistance Profile among Individuals on First-Line ART.
Autorzy:
Nannyonjo M; Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe P.O. Box 49, Uganda.
Omooja J; Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe P.O. Box 49, Uganda.; Uganda Virus Research Institute, Entebbe P.O. Box 49, Uganda.
Bugembe DL; Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe P.O. Box 49, Uganda.
Bbosa N; Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe P.O. Box 49, Uganda.
Lunkuse S; Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe P.O. Box 49, Uganda.
Nabirye SE; Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe P.O. Box 49, Uganda.
Nassolo F; Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe P.O. Box 49, Uganda.
Namagembe H; Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe P.O. Box 49, Uganda.
Abaasa A; Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe P.O. Box 49, Uganda.
Kazibwe A; Department of Molecular Biology, College of Veterinary Medicine, Makerere University, Kampala P.O. Box 7072, Uganda.
Kaleebu P; Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe P.O. Box 49, Uganda.; Uganda Virus Research Institute, Entebbe P.O. Box 49, Uganda.
Ssemwanga D; Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe P.O. Box 49, Uganda.; Uganda Virus Research Institute, Entebbe P.O. Box 49, Uganda.
Pokaż więcej
Źródło:
Viruses [Viruses] 2024 Sep 13; Vol. 16 (9). Date of Electronic Publication: 2024 Sep 13.
Typ publikacji:
Journal Article
MeSH Terms:
HIV-1*/genetics
HIV-1*/drug effects
Drug Resistance, Viral*/genetics
HIV Infections*/virology
HIV Infections*/drug therapy
High-Throughput Nucleotide Sequencing*
Anti-HIV Agents*/therapeutic use
Anti-HIV Agents*/pharmacology
Genotype*
Mutation*
Humans ; Male ; Female ; Adult ; Middle Aged ; Viral Load ; Antiretroviral Therapy, Highly Active
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Mapping Transmission Dynamics and Drug Resistance Surveillance in the Cyprus HIV-1 Epidemic (2017-2021).
Autorzy:
Topcu C; Laboratory of Biotechnology and Molecular Virology, Department of Biological Sciences, University of Cyprus, 2109 Nicosia, Cyprus.
Vrancken B; Spatial Epidemiology Lab (SpELL), Université Libre de Bruxelles, 1050 Bruxelles, Belgium.; Laboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, 3000 Leuven, Belgium.
Rodosthenous JH; Laboratory of Biotechnology and Molecular Virology, Department of Biological Sciences, University of Cyprus, 2109 Nicosia, Cyprus.
van de Vijver D; Department of Viroscience, Erasmus University Medical Centre, 3015 GD Rotterdam, The Netherlands.
Siakallis G; AIDS Clinic, Larnaca General Hospital, 6043 Larnaca, Cyprus.
Lemey P; Laboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, 3000 Leuven, Belgium.
Kostrikis LG; Laboratory of Biotechnology and Molecular Virology, Department of Biological Sciences, University of Cyprus, 2109 Nicosia, Cyprus.; Cyprus Academy of Sciences, Letters, and Arts, 1011 Nicosia, Cyprus.
Pokaż więcej
Źródło:
Viruses [Viruses] 2024 Sep 11; Vol. 16 (9). Date of Electronic Publication: 2024 Sep 11.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/epidemiology
HIV Infections*/transmission
HIV Infections*/virology
HIV Infections*/drug therapy
HIV-1*/genetics
HIV-1*/drug effects
HIV-1*/classification
Drug Resistance, Viral*/genetics
Epidemics*
Phylogeny*
Cyprus/epidemiology ; Humans ; Male ; Female ; Adult ; Molecular Epidemiology ; Middle Aged ; Young Adult ; Genetic Variation ; Adolescent ; Genotype ; Anti-HIV Agents/therapeutic use ; Anti-HIV Agents/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Spatial technologies to evaluate the HIV-1 reservoir and its microenvironment in the lymph node.
Autorzy:
Zaman F; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Smith ML; Department of Biochemistry and Molecular Genetics, University of Louisville School of Medicine, Louisville, Kentucky, USA.
Balagopal A; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Durand CM; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Redd AD; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Tobian AAR; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Pokaż więcej
Źródło:
MBio [mBio] 2024 Aug 14; Vol. 15 (8), pp. e0190924. Date of Electronic Publication: 2024 Jul 26.
Typ publikacji:
Journal Article; Review
MeSH Terms:
HIV-1*/physiology
HIV-1*/genetics
HIV-1*/immunology
Lymph Nodes*/virology
Lymph Nodes*/immunology
HIV Infections*/immunology
HIV Infections*/virology
HIV Infections*/drug therapy
Humans ; CD4-Positive T-Lymphocytes/immunology ; CD4-Positive T-Lymphocytes/virology ; Germinal Center/immunology ; Germinal Center/virology ; Cellular Microenvironment ; Virus Replication ; Virus Latency ; CD8-Positive T-Lymphocytes/immunology ; Proviruses/genetics
Czasopismo naukowe
Full Text Finder  Link otwiera się w nowym oknieSzczegóły
Tytuł:
MX2 forms nucleoporin-comprising cytoplasmic biomolecular condensates that lure viral capsids.
Autorzy:
Moschonas GD; VIB Center for Medical Biotechnology, VIB, Technologiepark-Zwijnaarde 75, 9052 Ghent, Belgium; Department of Biochemistry and Microbiology, Ghent University, Technologiepark-Zwijnaarde 75, 9052 Ghent, Belgium.
Delhaye L; VIB Center for Medical Biotechnology, VIB, Technologiepark-Zwijnaarde 75, 9052 Ghent, Belgium; Department of Biomolecular Medicine, Ghent University, Technologiepark-Zwijnaarde 75, 9052 Ghent, Belgium.
Cooreman R; VIB Center for Medical Biotechnology, VIB, Technologiepark-Zwijnaarde 75, 9052 Ghent, Belgium; Department of Biochemistry and Microbiology, Ghent University, Technologiepark-Zwijnaarde 75, 9052 Ghent, Belgium.
Hüsers F; Institute of Virology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany; RESIST-Cluster of Excellence, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.
Bhat A; Department of Pharmacological and Pharmaceutical Sciences, Laboratory of Molecular Virology and Gene Therapy, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.
Stylianidou Z; HIV Cure Research Center, Department of Internal Medicine and Pediatrics, Ghent University, 9000 Ghent, Belgium.
De Bousser E; VIB Center for Medical Biotechnology, VIB, Technologiepark-Zwijnaarde 75, 9052 Ghent, Belgium; Department of Biochemistry and Microbiology, Ghent University, Technologiepark-Zwijnaarde 75, 9052 Ghent, Belgium; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
De Pryck L; VIB Center for Medical Biotechnology, VIB, Technologiepark-Zwijnaarde 75, 9052 Ghent, Belgium; Department of Biochemistry and Microbiology, Ghent University, Technologiepark-Zwijnaarde 75, 9052 Ghent, Belgium; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
Grzesik H; VIB Center for Medical Biotechnology, VIB, Technologiepark-Zwijnaarde 75, 9052 Ghent, Belgium; Department of Biomolecular Medicine, Ghent University, Technologiepark-Zwijnaarde 75, 9052 Ghent, Belgium.
De Sutter D; VIB Center for Medical Biotechnology, VIB, Technologiepark-Zwijnaarde 75, 9052 Ghent, Belgium; Department of Biomolecular Medicine, Ghent University, Technologiepark-Zwijnaarde 75, 9052 Ghent, Belgium.
Parthoens E; VIB Center for Inflammation Research, Technologiepark-Zwijnaarde 71, 9052 Ghent, Belgium; Department of Biomedical Molecular Biology, Ghent University, 9052 Ghent, Belgium; VIB BioImaging Core, VIB, 9052 Ghent, Belgium.
De Smet AS; VIB Center for Medical Biotechnology, VIB, Technologiepark-Zwijnaarde 75, 9052 Ghent, Belgium; Department of Biochemistry and Microbiology, Ghent University, Technologiepark-Zwijnaarde 75, 9052 Ghent, Belgium.
Maciejczuk A; VIB Center for Medical Biotechnology, VIB, Technologiepark-Zwijnaarde 75, 9052 Ghent, Belgium; Department of Biomolecular Medicine, Ghent University, Technologiepark-Zwijnaarde 75, 9052 Ghent, Belgium.
Lippens S; VIB Center for Inflammation Research, Technologiepark-Zwijnaarde 71, 9052 Ghent, Belgium; VIB BioImaging Core, VIB, 9052 Ghent, Belgium.
Callewaert N; VIB Center for Medical Biotechnology, VIB, Technologiepark-Zwijnaarde 75, 9052 Ghent, Belgium; Department of Biochemistry and Microbiology, Ghent University, Technologiepark-Zwijnaarde 75, 9052 Ghent, Belgium.
Vandekerckhove L; HIV Cure Research Center, Department of Internal Medicine and Pediatrics, Ghent University, 9000 Ghent, Belgium.
Debyser Z; Department of Pharmacological and Pharmaceutical Sciences, Laboratory of Molecular Virology and Gene Therapy, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.
Sodeik B; Institute of Virology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany; RESIST-Cluster of Excellence, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany; DZIF-German Centre for Infection Research, Partner site Hannover-Braunschweig, Germany.
Eyckerman S; VIB Center for Medical Biotechnology, VIB, Technologiepark-Zwijnaarde 75, 9052 Ghent, Belgium; Department of Biomolecular Medicine, Ghent University, Technologiepark-Zwijnaarde 75, 9052 Ghent, Belgium. Electronic address: .
Saelens X; VIB Center for Medical Biotechnology, VIB, Technologiepark-Zwijnaarde 75, 9052 Ghent, Belgium; Department of Biochemistry and Microbiology, Ghent University, Technologiepark-Zwijnaarde 75, 9052 Ghent, Belgium. Electronic address: .
Pokaż więcej
Źródło:
Cell host & microbe [Cell Host Microbe] 2024 Oct 09; Vol. 32 (10), pp. 1705-1724.e14.
Typ publikacji:
Journal Article
MeSH Terms:
Herpesvirus 1, Human*/physiology
Herpesvirus 1, Human*/metabolism
Capsid*/metabolism
HIV-1*/metabolism
HIV-1*/physiology
Myxovirus Resistance Proteins*/metabolism
Myxovirus Resistance Proteins*/genetics
Biomolecular Condensates*/metabolism
Cytoplasm*/metabolism
Nuclear Pore Complex Proteins*/metabolism
Humans ; Nuclear Pore/metabolism ; HeLa Cells ; HEK293 Cells
Czasopismo naukowe
Full Text Finder  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Susceptibility to lenacapavir, fostemsavir and broadly neutralizing antibodies in French primary HIV-1 infected patients in 2020-2023.
Autorzy:
Chaix ML; Laboratoire de virologie, Hôpital Saint-Louis, APHP, Paris, France.; INSERM, U944, Université Paris Cité, Paris, France.
Terracol L; Laboratoire de virologie, Hôpital Saint-Louis, APHP, Paris, France.
Nere ML; Laboratoire de virologie, Hôpital Saint-Louis, APHP, Paris, France.
Stefic K; INSERM, U1259, Université de Tours, Tours, France.; Laboratoire de Virologie, Centre Hospitalier Régional Universitaire de Tours, Tours, France.
Lascoux-Combe C; Department of Maladies Infectieuses, Hôpital Saint-Louis-Lariboisière, Assistance Publique Hôpitaux de Paris, Paris, France.
Manda V; Department of Maladies Infectieuses, Hôpital Saint-Louis-Lariboisière, Assistance Publique Hôpitaux de Paris, Paris, France.
Sellier P; Department of Maladies Infectieuses, Hôpital Saint-Louis-Lariboisière, Assistance Publique Hôpitaux de Paris, Paris, France.
Maylin S; Laboratoire de virologie, Hôpital Saint-Louis, APHP, Paris, France.
Molina JM; INSERM, U944, Université Paris Cité, Paris, France.; Department of Maladies Infectieuses, Hôpital Saint-Louis-Lariboisière, Assistance Publique Hôpitaux de Paris, Paris, France.
Liegeon G; Department of Maladies Infectieuses, Hôpital Saint-Louis-Lariboisière, Assistance Publique Hôpitaux de Paris, Paris, France.
Delaugerre C; Laboratoire de virologie, Hôpital Saint-Louis, APHP, Paris, France.; INSERM, U944, Université Paris Cité, Paris, France.
Salmona M; Laboratoire de virologie, Hôpital Saint-Louis, APHP, Paris, France.; INSERM, U976 Team INSIGHT, Université Paris Cité, Paris, France.
Pokaż więcej
Źródło:
Journal of medical virology [J Med Virol] 2024 Oct; Vol. 96 (10), pp. e29948.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/virology
HIV Infections*/drug therapy
HIV Infections*/epidemiology
HIV Infections*/immunology
HIV-1*/drug effects
HIV-1*/immunology
HIV-1*/genetics
Antibodies, Neutralizing*/immunology
Anti-HIV Agents*/therapeutic use
Anti-HIV Agents*/pharmacology
Drug Resistance, Viral*/genetics
Humans ; France/epidemiology ; Male ; Female ; Adult ; Middle Aged ; Organophosphates/pharmacology ; Genotype ; HIV Antibodies/immunology ; Piperazines
Czasopismo naukowe
Full Text Finder  Link otwiera się w nowym oknieSzczegóły
Tytuł:
HIV-1 genotypic resistance testing using single molecule real-time sequencing.
Autorzy:
Raymond S; INSERM UMR1291 - CNRS UMR 5051 - Université Toulouse III, Toulouse Institute for Infectious and Inflammatory Diseases, Toulouse, France; CHU de Toulouse, Hôpital Purpan, Laboratoire de Virologie, Toulouse, France. Electronic address: .
Jeanne N; CHU de Toulouse, Hôpital Purpan, Laboratoire de Virologie, Toulouse, France.
Vellas C; INSERM UMR1291 - CNRS UMR 5051 - Université Toulouse III, Toulouse Institute for Infectious and Inflammatory Diseases, Toulouse, France; CHU de Toulouse, Hôpital Purpan, Laboratoire de Virologie, Toulouse, France.
Nicot F; CHU de Toulouse, Hôpital Purpan, Laboratoire de Virologie, Toulouse, France.
Saune K; CHU de Toulouse, Hôpital Purpan, Laboratoire de Virologie, Toulouse, France.
Ranger N; CHU de Toulouse, Hôpital Purpan, Laboratoire de Virologie, Toulouse, France.
Latour J; CHU de Toulouse, Hôpital Purpan, Laboratoire de Virologie, Toulouse, France.
Carcenac R; CHU de Toulouse, Hôpital Purpan, Laboratoire de Virologie, Toulouse, France.
Harter A; CHU de Toulouse, Hôpital Purpan, Laboratoire de Virologie, Toulouse, France.
Delobel P; INSERM UMR1291 - CNRS UMR 5051 - Université Toulouse III, Toulouse Institute for Infectious and Inflammatory Diseases, Toulouse, France; CHU de Toulouse, Service des Maladies Infectieuses et Tropicales, Toulouse, France.
Izopet J; INSERM UMR1291 - CNRS UMR 5051 - Université Toulouse III, Toulouse Institute for Infectious and Inflammatory Diseases, Toulouse, France; CHU de Toulouse, Hôpital Purpan, Laboratoire de Virologie, Toulouse, France.
Pokaż więcej
Źródło:
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology [J Clin Virol] 2024 Oct; Vol. 174, pp. 105717. Date of Electronic Publication: 2024 Jul 24.
Typ publikacji:
Journal Article; Evaluation Study; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV-1*/genetics
HIV-1*/drug effects
HIV Infections*/virology
Drug Resistance, Viral*/genetics
High-Throughput Nucleotide Sequencing*/methods
Genotype*
Viral Load*
Humans ; Prospective Studies ; Genotyping Techniques/methods ; RNA, Viral/genetics ; Anti-HIV Agents/pharmacology ; Anti-HIV Agents/therapeutic use ; Microbial Sensitivity Tests/methods ; Sensitivity and Specificity ; Sequence Analysis, DNA ; Mutation
Czasopismo naukowe
Full Text Finder  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Impact of hormonal therapy on HIV-1 immune markers in cis women and gender minorities.
Autorzy:
Pasin C; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.; Collegium Helveticum, Zurich, Switzerland.
Nuñez DG; Center for Gender Variance, Department of Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital Basel, Basel, Switzerland.
Kusejko K; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
Hachfeld A; Department of Infectious Diseases, University Hospital Bern, Bern, Switzerland.
Buvelot H; Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.
Cavassini M; Division of Infectious Diseases, Lausanne University Hospital, Lausanne, Switzerland.
Damonti L; Department of Infectious Diseases, University Hospital Bern, Bern, Switzerland.; Ente Ospedaliero Cantonale, Division of Infectious Diseases, Regional Hospital Lugano, Lugano, Switzerland.
Fux C; Department of Infectious Diseases and Hospital Hygiene, Kantonsspital Aarau, Aarau, Switzerland.
de Tejada BM; Department of Pediatrics, Gynecology and Obstetrics, University Hospitals of Geneva and Faculty of Medicine, Geneva, Switzerland.
Notter J; Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
Trkola A; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
Günthard HF; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
Aebi-Popp K; Department of Infectious Diseases, University Hospital Bern, Bern, Switzerland.
Kouyos RD; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
Abela IA; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
Pokaż więcej
Corporate Authors:
Swiss HIV Cohort Study
Źródło:
HIV medicine [HIV Med] 2024 Oct; Vol. 25 (10), pp. 1112-1124. Date of Electronic Publication: 2024 Jun 03.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/drug therapy
HIV Infections*/immunology
HIV-1*/immunology
Biomarkers*/blood
Humans ; Female ; Male ; Adult ; Middle Aged ; Transgender Persons ; Sexual and Gender Minorities ; Switzerland ; CD4 Lymphocyte Count ; Cohort Studies ; CD4-CD8 Ratio
Czasopismo naukowe
Full Text Finder  Link otwiera się w nowym oknieSzczegóły
Tytuł:
[The effect of sodium deoxyribonucleate with iron complex on the expression of surface markers of MT-4 cells infected with human immunodeficiency virus type 1 (HIV-1) (Retroviridae: Primate lentivirus group )].
Autorzy:
Nosik DN; FSBI «National Research Centre for Epidemiology and Microbiology named after the honorary academician N.F. Gamaleya» of the Ministry of Health of Russia.
Kalnina LB; FSBI «National Research Centre for Epidemiology and Microbiology named after the honorary academician N.F. Gamaleya» of the Ministry of Health of Russia.
Selimova LM; FSBI «National Research Centre for Epidemiology and Microbiology named after the honorary academician N.F. Gamaleya» of the Ministry of Health of Russia.
Kaplina EN; LLC «PharmPak».
Pokaż więcej
Źródło:
Voprosy virusologii [Vopr Virusol] 2024 Sep 26; Vol. 69 (4), pp. 309-319. Date of Electronic Publication: 2024 Sep 26.
Typ publikacji:
English Abstract; Journal Article
MeSH Terms:
HIV-1*/drug effects
HIV-1*/genetics
Iron*/metabolism
Humans ; Virus Replication/drug effects ; Cell Line ; HIV Infections/virology ; HIV Infections/drug therapy ; HIV Infections/genetics ; HLA-DR Antigens/genetics ; HLA-DR Antigens/metabolism ; CD28 Antigens/metabolism ; CD28 Antigens/genetics ; ADP-ribosyl Cyclase 1/genetics ; ADP-ribosyl Cyclase 1/metabolism ; CD4 Antigens/metabolism ; CD4 Antigens/genetics
Czasopismo naukowe
Full Text Finder  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Signal peptide exchange alters HIV-1 envelope antigenicity and immunogenicity.
Autorzy:
Upadhyay C; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Rao P; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Behzadi MA; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Feyznezhad R; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Lambert GS; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Kumar R; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Kumar M; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Yang W; Department of Pathology, Johns Hopkins University, Baltimore, MD, United States.
Jiang X; Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY, United States.
Luo CC; Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY, United States.
Nadas A; Department of Environment Medicine, New York University Grossman School of Medicine, New York, NY, United States.
Arthos J; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Kong XP; Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY, United States.
Zhang H; Department of Pathology, Johns Hopkins University, Baltimore, MD, United States.
Hioe CE; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Research Service, James J. Peters VA Medical Center, Bronx, NY, United States.
Duty JA; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Sep 24; Vol. 15, pp. 1476924. Date of Electronic Publication: 2024 Sep 24 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
HIV-1*/immunology
HIV Antibodies*/immunology
HIV Envelope Protein gp120*/immunology
AIDS Vaccines*/immunology
Protein Sorting Signals*
Animals ; Mice ; Humans ; Antibodies, Monoclonal/immunology ; HIV Envelope Protein gp160/immunology ; Antibodies, Neutralizing/immunology ; Glycosylation ; Mice, Inbred BALB C ; Female ; HIV Infections/immunology ; HIV Infections/prevention & control ; HIV Infections/virology
Czasopismo naukowe
Full Text Finder  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Decoupling HIV-1 antiretroviral drug inhibition from plasma antibody activity to evaluate broadly neutralizing antibody therapeutics and vaccines.
Autorzy:
Schwarzmüller M; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.
Lozano C; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.
Schanz M; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.
Abela IA; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, 8091 Zurich, Switzerland.
Grosse-Holz S; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.
Epp S; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.
Curcio M; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.
Greshake J; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.
Rusert P; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.
Huber M; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.
Kouyos RD; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, 8091 Zurich, Switzerland.
Günthard HF; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, 8091 Zurich, Switzerland.
Trkola A; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland. Electronic address: .
Pokaż więcej
Corporate Authors:
Swiss HIV Cohort Study
Źródło:
Cell reports. Medicine [Cell Rep Med] 2024 Sep 17; Vol. 5 (9), pp. 101702. Date of Electronic Publication: 2024 Aug 30.
Typ publikacji:
Journal Article
MeSH Terms:
HIV-1*/immunology
HIV-1*/drug effects
HIV Infections*/drug therapy
HIV Infections*/immunology
HIV Infections*/virology
HIV Infections*/blood
HIV Antibodies*/immunology
HIV Antibodies*/blood
Antibodies, Neutralizing*/immunology
Antibodies, Neutralizing*/blood
AIDS Vaccines*/immunology
AIDS Vaccines*/therapeutic use
Humans ; Anti-Retroviral Agents/therapeutic use ; Anti-HIV Agents/therapeutic use ; Anti-HIV Agents/pharmacology ; Broadly Neutralizing Antibodies/immunology ; Broadly Neutralizing Antibodies/therapeutic use ; Neutralization Tests/methods
Czasopismo naukowe
Full Text Finder  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Determinants of the interaction between the 5'-leader of HIV-1 genome and human lysyl-tRNA synthetase in reverse transcription primer release process.
Autorzy:
Liu Y; Institute of Life Sciences, Chongqing Medical University, Chongqing, China.
Luo Z; Institute of Life Sciences, Chongqing Medical University, Chongqing, China.
Chen X; Institute of Life Sciences, Chongqing Medical University, Chongqing, China.
Yang X; Institute of Life Sciences, Chongqing Medical University, Chongqing, China.
Qi Q; Institute of Life Sciences, Chongqing Medical University, Chongqing, China.
Alifu M; Institute of Life Sciences, Chongqing Medical University, Chongqing, China.
Tao C; Institute of Life Sciences, Chongqing Medical University, Chongqing, China.
Cui W; Institute of Life Sciences, Chongqing Medical University, Chongqing, China.
Liu M; Institute of Life Sciences, Chongqing Medical University, Chongqing, China. Electronic address: .
Wang W; Institute of Life Sciences, Chongqing Medical University, Chongqing, China. Electronic address: .
Pokaż więcej
Źródło:
Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2024 Sep 17; Vol. 725, pp. 150252. Date of Electronic Publication: 2024 Jun 10.
Typ publikacji:
Journal Article
MeSH Terms:
Lysine-tRNA Ligase*/metabolism
Lysine-tRNA Ligase*/chemistry
Lysine-tRNA Ligase*/genetics
HIV-1*/genetics
HIV-1*/enzymology
Reverse Transcription*
Genome, Viral*
Nucleic Acid Conformation*
Humans ; RNA, Viral/metabolism ; RNA, Viral/chemistry ; RNA, Viral/genetics ; 5' Untranslated Regions ; Protein Binding
Czasopismo naukowe
Full Text Finder  Link otwiera się w nowym oknieSzczegóły
Tytuł:
HIV drug resistance: analysis of viral genotypes and mutation loci in people living with HIV in Chongqing, China (2016-2023).
Autorzy:
Gao W; Department of Medical Laboratory Medicine, Chongqing Public Health Medical Center, Chongqing, China.
Zhou G; Department of Medical Laboratory Medicine, Chongqing Public Health Medical Center, Chongqing, China.
Li M; Department of Medical Laboratory Medicine, Chongqing Public Health Medical Center, Chongqing, China.
Wang P; Department of Medical Laboratory Medicine, Chongqing Public Health Medical Center, Chongqing, China.
Li J; Department of Medical Laboratory Medicine, Chongqing Public Health Medical Center, Chongqing, China.
Deng R; Department of Medical Laboratory Medicine, Chongqing Public Health Medical Center, Chongqing, China. .
Pokaż więcej
Źródło:
AIDS research and therapy [AIDS Res Ther] 2024 Sep 13; Vol. 21 (1), pp. 62. Date of Electronic Publication: 2024 Sep 13.
Typ publikacji:
Journal Article
MeSH Terms:
HIV-1*/genetics
HIV-1*/drug effects
HIV Infections*/drug therapy
HIV Infections*/virology
HIV Infections*/epidemiology
Drug Resistance, Viral*/genetics
Genotype*
Mutation*
Anti-HIV Agents*/therapeutic use
Anti-HIV Agents*/pharmacology
Humans ; China/epidemiology ; Retrospective Studies ; Male ; Female ; Adult ; Middle Aged ; Young Adult ; Reverse Transcriptase Inhibitors/therapeutic use ; Reverse Transcriptase Inhibitors/pharmacology ; Adolescent ; Aged
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Acetylation of SAMHD1 at lysine 580 is crucial for blocking HIV-1 infection.
Autorzy:
Bulnes-Ramos A; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Schott K; Host-Pathogen Interactions, Paul-Ehrlich-Institute, Langen, Germany.
Rabinowitz J; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Luchsinger C; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Bertelli C; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Miyagi E; Viral Biochemistry Section NIAID, NIH, Bethesda, Maryland, USA.
Yu CH; Department of Biochemistry, UTHSA, San Antonio, Texas, USA.
Persaud M; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Shepard C; Department of Pediatrics, Center for ViroScience and Cure, School of Medicine, Emory University, Atlanta, Georgia, USA.; Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
König R; Host-Pathogen Interactions, Paul-Ehrlich-Institute, Langen, Germany.
Kim B; Department of Pediatrics, Center for ViroScience and Cure, School of Medicine, Emory University, Atlanta, Georgia, USA.; Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
Ivanov DN; Department of Biochemistry, UTHSA, San Antonio, Texas, USA.
Strebel K; Viral Biochemistry Section NIAID, NIH, Bethesda, Maryland, USA.
Diaz-Griffero F; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Pokaż więcej
Źródło:
MBio [mBio] 2024 Sep 11; Vol. 15 (9), pp. e0195824. Date of Electronic Publication: 2024 Aug 20.
Typ publikacji:
Journal Article
MeSH Terms:
SAM Domain and HD Domain-Containing Protein 1*/metabolism
SAM Domain and HD Domain-Containing Protein 1*/genetics
HIV-1*/genetics
HIV-1*/physiology
Macrophages*/virology
Macrophages*/metabolism
Lysine*/metabolism
Protein Processing, Post-Translational*
HIV Infections*/virology
HIV Infections*/metabolism
Humans ; Acetylation ; THP-1 Cells ; B-Lymphocytes/virology ; B-Lymphocytes/metabolism
Czasopismo naukowe
Full Text Finder  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Exploring HIV-1 Maturation: A New Frontier in Antiviral Development.
Autorzy:
McGraw A; Department Biology, College of Arts and Sciences, American University, Washington, DC 20016, USA.
Hillmer G; Department Biology, College of Arts and Sciences, American University, Washington, DC 20016, USA.
Medehincu SM; Department Biology, College of Arts and Sciences, American University, Washington, DC 20016, USA.
Hikichi Y; Virus-Cell Interaction Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, MS 21702, USA.
Gagliardi S; Department Biology, College of Arts and Sciences, American University, Washington, DC 20016, USA.
Narayan K; Department Biology, College of Arts and Sciences, American University, Washington, DC 20016, USA.
Tibebe H; Department Biology, College of Arts and Sciences, American University, Washington, DC 20016, USA.
Marquez D; Department Biology, College of Arts and Sciences, American University, Washington, DC 20016, USA.
Mei Bose L; Department Biology, College of Arts and Sciences, American University, Washington, DC 20016, USA.
Keating A; Department Biology, College of Arts and Sciences, American University, Washington, DC 20016, USA.
Izumi C; Department Biology, College of Arts and Sciences, American University, Washington, DC 20016, USA.
Peese K; ViiV Healthcare, 36 E. Industrial Road, Branford, CT 06405, USA.
Joshi S; ViiV Healthcare, 36 E. Industrial Road, Branford, CT 06405, USA.
Krystal M; ViiV Healthcare, 36 E. Industrial Road, Branford, CT 06405, USA.
DeCicco-Skinner KL; Department Biology, College of Arts and Sciences, American University, Washington, DC 20016, USA.
Freed EO; Virus-Cell Interaction Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, MS 21702, USA.
Sardo L; ViiV Healthcare, 36 E. Industrial Road, Branford, CT 06405, USA.
Izumi T; Department Biology, College of Arts and Sciences, American University, Washington, DC 20016, USA.; District of Columbia Center for AIDS Research, Washington, DC 20052, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2024 Sep 06; Vol. 16 (9). Date of Electronic Publication: 2024 Sep 06.
Typ publikacji:
Journal Article; Review
MeSH Terms:
HIV-1*/physiology
HIV-1*/drug effects
Virus Assembly*
Virion*/metabolism
Virion*/physiology
Virus Replication*
Humans ; HIV Infections/virology ; HIV Infections/drug therapy ; Anti-HIV Agents/pharmacology ; gag Gene Products, Human Immunodeficiency Virus/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparison of Different HIV-1 Resistance Interpretation Tools for Next-Generation Sequencing in Italy.
Autorzy:
Armenia D; Departmental Faculty, UniCamillus, Saint Camillus International University of Health Sciences, 00131 Rome, Italy.
Carioti L; Department of Experimental Medicine, University of Rome 'Tor Vergata', 00133 Rome, Italy.
Micheli V; Laboratory of Clinical Microbiology, Virology and Bioemergencies, ASST Fatebenefratelli Sacco-University of Milan, 20157 Milan, Italy.
Bon I; Microbiology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Allice T; Laboratory of Microbiology and Virology, Amedeo di Savoia Hospital, 10149 Turin, Italy.
Bonura C; Dipartimento di Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza 'G. D'Alessandro' (PROSAMI), Azienda Ospedaliera Universitaria Policlinico 'P. Giaccone'-University of Palermo, 90127 Palermo, Italy.
Bruzzone B; Hygiene Unit, Ospedale Policlinico San Martino, 16132 Genoa, Italy.
Bracchitta F; Laboratory of Clinical Microbiology, Virology and Bioemergencies, ASST Fatebenefratelli Sacco-University of Milan, 20157 Milan, Italy.
Cerutti F; Laboratory of Microbiology and Virology, Amedeo di Savoia Hospital, 10149 Turin, Italy.
Giammanco GM; Dipartimento di Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza 'G. D'Alessandro' (PROSAMI), Azienda Ospedaliera Universitaria Policlinico 'P. Giaccone'-University of Palermo, 90127 Palermo, Italy.
Stefanelli F; Hygiene Unit, Ospedale Policlinico San Martino, 16132 Genoa, Italy.
Bonifacio MA; Section of Experimental and Clinical Pathology, Department of Precision and Regenerative Medicine and Jonic Area, University of Bari, 70121 Bari, Italy.
Bertoli A; Virology Unit, Polyclinic of 'Tor Vergata', 00133 Rome, Italy.
Vatteroni M; Virology Unit, AOU Pisana, 56126 Pisa, Italy.
Ibba G; Microbiology and Virology Unit, Diagnostic Department, AOU Sassari, 07100 Sassari, Italy.
Novazzi F; Department of Medicine and Technological Innovation, University of Insubria, 21100 Varese, Italy.
Lipsi MR; Microbiology and Virology Unit, Policlinico Riuniti Foggia Hospital, 71121 Foggia, Italy.
Cuomo N; U.O.C. Microbiologia e Virologia, P.O. 'D.Cotugno'-AO dei Colli, 80100 Napoli, Italy.
Vicenti I; Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
Ceccherini-Silberstein F; Department of Experimental Medicine, University of Rome 'Tor Vergata', 00133 Rome, Italy.
Rossetti B; Infectious Disease Department, USL SUDEST, Toscana, Misericordia Hospital, 58100 Grosseto, Italy.
Bezenchek A; IPRO-InformaPRO S.r.l., 00152 Rome, Italy.; EuResist Network GEIE, 00152 Rome, Italy.
Saladini F; Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
Zazzi M; Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
Santoro MM; Department of Experimental Medicine, University of Rome 'Tor Vergata', 00133 Rome, Italy.
Pokaż więcej
Corporate Authors:
Italian HIV NGS network and the ARCA Cohort
Źródło:
Viruses [Viruses] 2024 Sep 06; Vol. 16 (9). Date of Electronic Publication: 2024 Sep 06.
Typ publikacji:
Journal Article; Comparative Study
MeSH Terms:
HIV-1*/genetics
HIV-1*/drug effects
High-Throughput Nucleotide Sequencing*/methods
Drug Resistance, Viral*/genetics
HIV Infections*/virology
Humans ; Italy ; Mutation ; Genotype ; RNA, Viral/genetics ; Anti-HIV Agents/pharmacology ; Anti-HIV Agents/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Interactome of the HIV-1 proteome and human host RNA.
Autorzy:
Schynkel T; HIV Cure Research Center, Department of Internal Medicine and Pediatrics, Ghent University and Ghent University Hospital, Ghent, 9000, Belgium.
Snippenberg WV; HIV Cure Research Center, Department of Internal Medicine and Pediatrics, Ghent University and Ghent University Hospital, Ghent, 9000, Belgium.; OncoRNALab, Center for Medical Genetics (CMGG), Ghent University, Ghent, 9000, Belgium.
Verniers K; OncoRNALab, Center for Medical Genetics (CMGG), Ghent University, Ghent, 9000, Belgium.
Jang GM; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California, San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA, 94158, USA.
Krogan NJ; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, 94158, USA.; Quantitative Biosciences Institute (QBI), University of California, San Francisco, CA, 94158, USA.; J. David Gladstone Institutes, San Francisco, CA, 94158, USA.
Mestdagh P; OncoRNALab, Center for Medical Genetics (CMGG), Ghent University, Ghent, 9000, Belgium.
Vandekerckhove L; HIV Cure Research Center, Department of Internal Medicine and Pediatrics, Ghent University and Ghent University Hospital, Ghent, 9000, Belgium. .
Trypsteen W; HIV Cure Research Center, Department of Internal Medicine and Pediatrics, Ghent University and Ghent University Hospital, Ghent, 9000, Belgium. .; OncoRNALab, Center for Medical Genetics (CMGG), Ghent University, Ghent, 9000, Belgium. .
Pokaż więcej
Źródło:
EMBO reports [EMBO Rep] 2024 Sep; Vol. 25 (9), pp. 4078-4090. Date of Electronic Publication: 2024 Aug 09.
Typ publikacji:
Journal Article
MeSH Terms:
HIV-1*/genetics
HIV-1*/metabolism
HIV-1*/physiology
Proteome*/metabolism
Virus Replication*/genetics
Humans ; Jurkat Cells ; Host-Pathogen Interactions/genetics ; Protein Binding ; Cyclin T/metabolism ; Cyclin T/genetics ; RNA, Messenger/metabolism ; RNA, Messenger/genetics ; HIV Infections/virology ; HIV Infections/metabolism ; HIV Infections/genetics ; RNA, Viral/metabolism ; RNA, Viral/genetics ; tat Gene Products, Human Immunodeficiency Virus/metabolism ; tat Gene Products, Human Immunodeficiency Virus/genetics ; Viral Proteins/metabolism ; Viral Proteins/genetics ; Ribosomal Proteins/metabolism ; Ribosomal Proteins/genetics ; RNA-Binding Proteins/metabolism ; RNA-Binding Proteins/genetics ; DNA-Binding Proteins/metabolism ; DNA-Binding Proteins/genetics
Czasopismo naukowe
Full Text Finder  Link otwiera się w nowym oknieSzczegóły
Tytuł:
"Evaluation of ELITE InGenius® integrative system for detection, quantification and monitoring of HIV-1 RNA in Cerebrospinal Fluid."
Autorzy:
Costanza G; Unit of Virology, Policlinic of Tor Vergata, Rome, Italy. Electronic address: .
Felici E; Unit of Virology, Policlinic of Tor Vergata, Rome, Italy. Electronic address: .
Velluso F; Unit of Virology, Policlinic of Tor Vergata, Rome, Italy. Electronic address: .
Grelli S; Unit of Virology, Policlinic of Tor Vergata, Rome, Italy; Department of Experimental Medicine, University of Rome Tor Vergata, Rome 00133, Italy. Electronic address: .
Paba P; Unit of Virology, Policlinic of Tor Vergata, Rome, Italy. Electronic address: .
Pokaż więcej
Źródło:
Journal of virological methods [J Virol Methods] 2024 Sep; Vol. 329, pp. 114996. Date of Electronic Publication: 2024 Jul 27.
Typ publikacji:
Journal Article; Evaluation Study; Comparative Study
MeSH Terms:
HIV-1*/genetics
HIV-1*/isolation & purification
RNA, Viral*/cerebrospinal fluid
RNA, Viral*/genetics
RNA, Viral*/blood
HIV Infections*/virology
HIV Infections*/cerebrospinal fluid
HIV Infections*/diagnosis
Humans ; Reproducibility of Results ; Reagent Kits, Diagnostic/standards ; Sensitivity and Specificity ; Viral Load/methods ; Molecular Diagnostic Techniques/methods ; Cerebrospinal Fluid/virology
Czasopismo naukowe
Full Text Finder  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The sensitivity of HIV-1 gp120 polymorphs to inhibition by temsavir correlates to temsavir binding on-rate.
Autorzy:
Wensel D; ViiV Healthcare, 36 E Industrial Road, Branford, CT, 06405, USA. Electronic address: .
Gartland M; ViiV Healthcare, 406 Blackwell Street, Suite 300, Durham, NC, 27701, USA.
Beloor J; ViiV Healthcare, 36 E Industrial Road, Branford, CT, 06405, USA.
Shetty KN; Domainex Ltd, Chesterford Research Park, Saffron Walden, CB10 1XL, UK.
Wolf J; Domainex Ltd, Chesterford Research Park, Saffron Walden, CB10 1XL, UK.
Stewart E; GSK, 1250 S Collegeville Road, Collegeville, PA, 19426, USA.
Clark A; ViiV Healthcare, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK.
Tenorio A; ViiV Healthcare, 36 E Industrial Road, Branford, CT, 06405, USA.
Krystal M; ViiV Healthcare, 36 E Industrial Road, Branford, CT, 06405, USA.
Pokaż więcej
Źródło:
Antiviral research [Antiviral Res] 2024 Sep; Vol. 229, pp. 105953. Date of Electronic Publication: 2024 Jul 01.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Envelope Protein gp120*/metabolism
HIV Envelope Protein gp120*/genetics
HIV Envelope Protein gp120*/chemistry
HIV-1*/drug effects
HIV-1*/genetics
Anti-HIV Agents*/pharmacology
Protein Binding*
CD4 Antigens*/metabolism
CD4 Antigens*/genetics
Humans ; Amino Acid Substitution ; Polymorphism, Genetic ; Drug Resistance, Viral ; Inhibitory Concentration 50 ; Kinetics
Czasopismo naukowe
Full Text Finder  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Methodological approaches to studying phase separation and HIV-1 replication: Current and future perspectives.
Autorzy:
Mouland AJ; Department of Medicine, McGill University, Montreal, Quebec, Canada. Electronic address: .
Chau BA; Department of Medicine, McGill University, Montreal, Quebec, Canada.
Uversky VN; Department of Molecular Medicine and Byrd Alzheimer's Research Institute, Morsani College of Medicine, University of South Florida, Tampa, FL, USA. Electronic address: .
Pokaż więcej
Źródło:
Methods (San Diego, Calif.) [Methods] 2024 Sep; Vol. 229, pp. 147-155. Date of Electronic Publication: 2024 Jul 15.
Typ publikacji:
Journal Article; Review
MeSH Terms:
HIV-1*/genetics
HIV-1*/physiology
Virus Replication*
Humans ; HIV Infections/virology ; Phase Separation ; RNA, Viral/genetics
Czasopismo naukowe
Full Text Finder  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Treatment Management Challenges in Naïve and Experienced HIV-1-Infected Individuals Carrying the M184V Mutation.
Autorzy:
Mimtsoudis I; Infectious Diseases Division 1st Internal Medicine Department, AHEPA University Hospital Thessaloniki, 54636 Thessaloniki, Greece.
Tsachouridou O; Infectious Diseases Division 1st Internal Medicine Department, AHEPA University Hospital Thessaloniki, 54636 Thessaloniki, Greece.
Akinosoglou K; Department of Internal Medicine and Infectious Diseases, University General Hospital of Patras, 26504 Patras, Greece.
Metallidis S; Infectious Diseases Division 1st Internal Medicine Department, AHEPA University Hospital Thessaloniki, 54636 Thessaloniki, Greece.
Pokaż więcej
Źródło:
Viruses [Viruses] 2024 Aug 30; Vol. 16 (9). Date of Electronic Publication: 2024 Aug 30.
Typ publikacji:
Journal Article; Review
MeSH Terms:
HIV-1*/genetics
HIV-1*/drug effects
HIV Infections*/drug therapy
HIV Infections*/virology
Drug Resistance, Viral*/genetics
Anti-HIV Agents*/therapeutic use
Mutation*
Humans ; HIV Reverse Transcriptase/genetics ; Lamivudine/therapeutic use ; Emtricitabine/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 81009

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies